BioMarin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. 

CEO
Alexander Hardy
CEOAlexander Hardy
Employees
3,040
Employees3,040
Headquarters
San Rafael, California
HeadquartersSan Rafael, California
Founded
1997
Founded1997
Employees
3,040
Employees3,040

BMRN Key Statistics

Market cap
9.98B
Market cap9.98B
Price-Earnings ratio
19.43
Price-Earnings ratio19.43
Dividend yield
Dividend yield
Average volume
3.20M
Average volume3.20M
High today
$52.49
High today$52.49
Low today
$51.14
Low today$51.14
Open price
$51.83
Open price$51.83
Volume
2.61M
Volume2.61M
52 Week high
$73.51
52 Week high$73.51
52 Week low
$51.10
52 Week low$51.10

BMRN News

TipRanks 2d
BioMarin: FDA accepts for Priority Review sBLA for Palynziq

BioMarin (BMRN) Pharmaceutical announced that the U.S. FDA has accepted for Priority Review the company’s Palynziq supplemental Biologics License Application to...

TipRanks 2d
Biomarin’s Acquisition Strategy: Navigating Risks and Challenges for Future Growth

Biomarin Pharmaceutical Inc. (BMRN) has disclosed a new risk, in the Corporate Activity and Growth category. Elevate Your Investing Strategy: Take advantage o...

The Motley Fool 2d
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday

Although the company recorded higher sales overall, it's decided to divest one of its products. BioMarin Pharmaceutical (BMRN +1.56%) reported its third-quarte...

Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday

Analyst ratings

82%

of 28 ratings
Buy
82.1%
Hold
17.9%
Sell
0%

More BMRN News

Nasdaq 3d
July 2026 Options Now Available For BioMarin Pharmaceutical

Investors in BioMarin Pharmaceutical Inc (Symbol: BMRN) saw new options begin trading today, for the July 2026 expiration. One of the key inputs that goes into...

July 2026 Options Now Available For BioMarin Pharmaceutical
TipRanks 3d
BioMarin price target lowered to $80 from $90 at Truist

Truist lowered the firm’s price target on BioMarin (BMRN) to $80 from $90 and keeps a Buy rating on the shares. The firm cites the company’s Q3 revenue miss as...

TipRanks 3d
BioMarin Pharmaceutical: Strong Growth Prospects and Strategic Initiatives Justify Buy Rating

Wedbush analyst Yun Zhong reiterated a Buy rating on BioMarin Pharmaceutical today and set a price target of $94.00. Elevate Your Investing Strategy: Take advan...

TipRanks 3d
BioMarin Pharmaceutical: Strategic Adjustments and Future Potential Justify Buy Rating Despite Revenue Miss

Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on BioMarin Pharmaceutical. The associated price target remains the same with $120.00. Elevate...

TipRanks 3d
BioMarin’s Vosoritide Study: A Potential Game-Changer for Hypochondroplasia Treatment

Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 3d
BioMarin’s Vosoritide Study: A Potential Game-Changer in Pediatric Growth Disorders

Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 3d
BioMarin’s Long-Term Study on BMN 270: A Potential Game Changer for Hemophilia A

Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.